News

Arkstone Unveils RightDose: Transforming Antimicrobial Management

Arkstone Unveils RightDose: Transforming Antimicrobial Management

Arkstone Introduces RightDose: A Clearer Path for Antimicrobial Dosing

Arkstone, a leader in laboratory infectious disease guidance and antimicrobial stewardship, has launched RightDose—a feature built to simplify how clinicians select and calculate antibiotic doses. Prescribing antibiotics can be complex, and that complexity only grows when caring for children. RightDose steps in with tailored dosing recommendations by age group so providers can move quickly and confidently while keeping treatments safe and effective.

Why Pediatric Dosing Demands Extra Care

Caring for neonates, infants, children, and adolescents isn’t just adult care in smaller doses. Each age group has distinct pharmacokinetic and pharmacodynamic considerations, and the stakes are high when precision matters. Without a single, reliable source to consult, clinicians often bounce between references, guidelines, and calculators—losing time and increasing the chance of error. RightDose brings this information into one place, helping providers find the right dose faster and with less friction.

Pediatric Dosing, Streamlined

RightDose compiles pediatric dosing information and serves it in a way that’s easy to use during real clinical work. Recommendations are tailored by age, and the feature doesn’t stop at pediatrics—its guidance extends to patients across the lifespan. When kidney or liver function should change how a drug is dosed, RightDose includes adjustments for renal and hepatic impairment, further tightening the fit between the patient and the prescription.

One Source for Comprehensive Dosing Guidance

At the core of RightDose is Arkstone’s robust drug database, which consolidates dosing recommendations drawn from trusted sources. Centralizing this information means clinicians can rely on a single, consistent reference instead of piecing together guidance from multiple manuals. The result: clearer, evidence-based direction that supports sound clinical decisions and a safer standard of care.

What Arkstone’s Leaders Are Saying

Dr. Ari Frenkel, Chief Science Officer at Arkstone, shared his enthusiasm regarding RightDose, stating, "This integration into our OneChoice platform marks a significant leap forward in our pursuit of precision medicine. With RightDose, we empower healthcare providers by offering detailed dosing instructions that consider the specific age and health condition of each patient."

Furthermore, Dave Gross, Chief Technology Officer, noted the innovative technology behind RightDose, emphasizing the complexity of its development. "Our sophisticated system matches an extensive array of drug dose combinations with the diverse needs of various age groups. This ensures that healthcare providers receive the most accurate dosing information, which is essential given the absence of a single comprehensive source for this critical data," he said.

Advancing Arkstone’s Work in Infectious Disease Care

The launch of RightDose continues Arkstone’s effort to make antimicrobial management clearer and safer. By pairing practical tools with reliable guidance, the company helps clinicians choose appropriate therapies with fewer workarounds and less guesswork. Better decisions at the point of care lead to better outcomes—patient by patient, day by day.

About Arkstone

Arkstone is focused on addressing antimicrobial resistance and supporting responsible antibiotic use. Using advanced artificial intelligence, Arkstone translates laboratory findings into actionable recommendations, so providers have current, accurate insights available when they need them most.

Frequently Asked Questions

What is RightDose?

RightDose is a feature within Arkstone’s OneChoice platform that delivers tailored antibiotic dosing recommendations. It aligns doses to the patient’s age group and clinical context so providers can prescribe with greater confidence and speed.

How does RightDose improve pediatric care?

It gathers dosing guidance for neonates, infants, children, and adolescents into one place, presenting clear recommendations that fit each age group. That consolidation shortens the search for answers and helps reduce dosing errors in a setting where small mistakes can have outsized effects.

Why does a centralized dosing database matter?

A single, trusted source means clinicians don’t have to cross-check multiple references or assemble dosing rules on the fly. Centralization saves time, reduces variability, and supports safer, more consistent prescribing.

What patient factors does RightDose consider?

Along with age-specific guidance, RightDose includes adjustments for renal and hepatic function. Those refinements help match the dose to the patient’s physiology, improving accuracy and supporting safer treatment plans.

How do healthcare providers benefit from using RightDose?

Providers gain faster access to clear, evidence-based dosing information, which can improve prescribing accuracy, streamline workflows, and support better patient outcomes—without hours spent searching through scattered resources.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ZEEKR's Shooting Brakes Dominate: Over 400K Sold

Updated Category News Views 4

ZEEKR's Stellar Performance in a Crowded Market Another month, another bumper crop for ZEEKR's shooting brakes. These beauties aren't just hanging in there; they're leading the pack. In August alone, global deliveries marched past the 10,000 mark for the third month running—a feat not easily achieved in today's saturated automotive landscape. It's no wonder the...

Continue Reading
Woodpack Global Unveils Crate Design System: A New Era Begins

Updated Category News Views 2

Innovating the Wooden Crate Landscape An old industry got a much-needed facelift today, folks. Woodpack Global has rolled out Crate Design System™ (CDS)—a snazzy new tool that's shaking up the wooden crate design landscape. It blows the dust off outdated design methods that have been collecting cobwebs since the '60s. That's right, we’re talking about a significant...

Continue Reading
Tampa General’s Innovation Excellence Earns No. 20 Spot

Updated Category News Views 7

A Bold Leap into Innovation at Tampa General There's a heck of a lot going on down in Tampa that's worth more than just a golf clap. Tampa General Hospital (TGH) just snagged the 20th spot on Fast Company's Best Workplaces for Innovators list, and let me tell you, that’s no small feat amidst the heavy hitters in verticals like biotech and consumer goods. It takes guts...

Continue Reading
Cap Juluca: Caribbean Luxury Redefined on Maundays Bay

Updated Category News Views 2

The Tranquil Call of Maundays Bay Find me dipping my toes in the sands of Maundays Bay come October 10, 2026, and you'll understand why this slice of Anguilla stakes its claim to being the best beach on the globe. Cap Juluca, that crown jewel of Caribbean luxury, swings open its doors once more, promising indulgence framed by turquoise waters and the soft whisper of white...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 3

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
Hair Syrup's Big U.S. Leap: Target Welcomes Viral Brand

Updated Category News Views 2

From Kitchen Experiment to U.S. Debut Here's a story that barely fits the tight mold of your typical business textbook. Hair Syrup, born from the brain of a university student tinkering at her kitchen table, is about to make waves across the pond. Lucie Macleod did what many dream of—she took a DIY hair oil project and spun it into a multimillion-dollar brand, now set...

Continue Reading
RevSystems Joins Elite OpenAI Partner Network

Updated Category News Views 3

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Continue Reading
Monib Zirvi's Dermatology Excellence Honored in 2026

Updated Category News Views 4

Trailblazer in Dermatology Recognized Again Fancy yourself a star in dermatology? Well, take notes from Dr. Monib A. Zirvi. The guy just got his due recognition from Marquis Who's Who for his sizable contributions to dermatology and research. For someone who's been at this game for over two decades, Zirvi doesn't just glide by on old merits. He's the real deal, and his...

Continue Reading
Sandbox VR Expands to Melbourne, Betting on Immersive Fun

Updated Category News Views 3

Sandbox VR Ventures into Melbourne's Heart Every now and then, a venture takes its ambitions and rolls the dice on a prime location. Sandbox VR is swaggering into Melbourne's bustling Central Business District, fresh out of its success on the Gold Coast. Opening this Melbourne venue on September 14 marks a significant leap in the company's Aussie expansion—a bold nod to...

Continue Reading
ABC Honors 2026 Spirit of the Heart Leaders

Updated Category News Views 4

Celebrating Champions of Cardiovascular Health In a world where accolades often feel as cold as the stock market after a crash, it’s heartening to see genuine recognition for those who are making actual, lasting impact. On October 3, 2026, the Association of Black Cardiologists (ABC) will hold its annual Spirit of the Heart Awards at none other than Cipriani Wall...

Continue Reading

Top 5 Most Recently Viewed Articles

Top UK Publisher Rankings Reveal Insights for Advertisers

Updated Category News Views 185

Pixalate Unveils the May 2025 Publisher Trust Index for the UK Pixalate has recently launched the May 2025 Publisher Trust Index (PTI), reflecting a comprehensive assessment of the quality of ad traffic across various digital platforms. This innovative ranking evaluates websites and mobile applications within the UK, highlighting respected names such as thetimes.co.uk,...

Continue Reading
Hurco Companies Inc. Expands Stock Buyback Program to 2026

Updated Category News Views 95

Big moves are in play at Hurco Companies Inc. (NASDAQ:HURC) as they extend their share repurchase program, showing the finance world they mean business. The Board of Directors has given the nod for this initiative to continue for another two years, now set to run until November 10, 2026. With a hefty $25 million authorized for buybacks and about $21.7 million left on the...

Continue Reading
Kuehn Law Investigates Potential Misconduct at Avantor, Inc.

Updated Category News Views 126

Kuehn Law Investigates Potential Misconduct at Avantor, Inc. Kuehn Law, a respected law firm specializing in shareholder litigation, has shifted its attention towards Avantor, Inc. (NYSE: AVTR). The firm is examining whether certain officers and directors of Avantor have breached their fiduciary duties towards shareholders. This investigation has been prompted by serious...

Continue Reading
Building Strategies for the Evolving Housing Needs in GTA

Updated Category News Views 235

Growing Housing Challenges in the Greater Toronto Area The Greater Toronto Area (GTA) is facing a pressing issue regarding housing availability and demographic shifts. Recent research emphasizes the urgent requirement to ramp up housing construction rates and modify the types of housing being developed to address the needs of a diversifying population. It's clear that the...

Continue Reading
Exploring Week 36 of the Trump Administration's Achievements

Updated Category News Views 287

Week 36 of the Trump Administration: Key Highlights The latest article from ThinkCareBelieve presents an in-depth overview of Week 36 of the Trump Administration. It encapsulates significant events through news articles, videos, and insights that underscore the continuing evolution of America's trajectory. This period is pivotal in shaping a stronger and more informed...

Continue Reading